文献速递角膜与眼表疾病白内障与屈光手术

新型冠状病毒感染康复者角膜基质分析及相关眼部表现

Corneal Stroma Analysis and Related Ocular Manifestations in Recovered COVID-19 Patients.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

本研究获取康复期(135天内)COVID-19患者与健康对照者SMILE术后新鲜角膜微透镜,实验验证SARS-CoV-2易感性、形态学改变与免疫反应,并用Pentacam HR、广域OCT和SP-1P评估角膜光学密度、上皮厚度及内皮参数,随访至术后3个月。结果显示角膜对SARS-CoV-2易感,康复后45至75天IL-6升高,60D至75D组角膜中基质神经长度和分支 initially较高并于第135天恢复至对照水平,CD及内皮六角形细胞比率呈类似趋势,但未影响SMILE手术有效性、安全性或可预测性。

要点

  • 康复期角膜微透镜中检测到SARS-CoV-2受体CD147和ACE2及刺突蛋白残留(58例中4例)。
  • SARS-CoV-2感染触发角膜基质免疫反应,康复后45至75天IL-6升高,约第105天降低。
  • 60D至75D组角膜中基质神经长度和分支 initially较高,第135天恢复至对照水平。

核心结论

  • SARS-CoV-2在康复后诱导角膜基质形态和功能的时间性改变,为COVID-19后角膜健康与屈光手术管理提供理论依据。

研究设计与样本

  • 获取康复期(135天内)COVID-19患者与健康对照者SMILE术后新鲜角膜微透镜进行实验验证,评估SARS-CoV-2易感性、形态学改变和角膜基质免疫反应。
  • 使用Pentacam HR测量角膜光学密度,广域OCT评估角膜上皮厚度,非接触式角膜内皮镜SP-1P评估内皮参数,所有患者随访至SMILE术后3个月。

主要发现

  • 角膜对SARS-CoV-2易感,康复期角膜微透镜中存在SARS-CoV-2受体CD147和ACE2及刺突蛋白残留(58例中4例)。
  • SARS-CoV-2感染触发角膜基质免疫反应,康复后45至75天IL-6水平升高,约第105天降低。
  • 60D至75D组角膜中基质神经长度和分支 initially高于对照,第135天恢复至对照水平。
  • 0至2区和2至6区角膜光学密度及内皮细胞六角形细胞比率呈类似趋势,角膜上皮厚度保持一致。
  • 上述改变未影响康复后SMILE手术的有效性、安全性或可预测性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to assess the impact of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on corneal stroma characteristics, ocular manifestations, and post-recovery refractive surgery outcomes after varying recovery durations. METHODS: Fresh corneal lenticules from patients with post-coronavirus disease 2019 (COVID-19; recovered within 135 days) and healthy controls (HCs) after small incision lenticule extraction (SMILE) surgery were obtained for experimental validation of SARS-CoV-2 susceptibility, morphological changes, and immune response of the corneal stroma. Corneal optical density (CD) was measured using the Pentacam HR. Corneal epithelium thickness (ET) and endothelium parameters were evaluated by wide-field optical coherence tomography (OCT) and non-contact specular microscopy (SP-1P), respectively. All the patients were assessed after SMILE surgery until 3 month of follow-up. RESULTS: The cornea was susceptible to SARS-CoV-2 with the presence of SARS-CoV-2 receptors (CD147 and ACE2) and spike protein remnants (4 out of 58) in post-recovery corneal lenticules. Moreover, SARS-CoV-2 infection triggered immune responses in the corneal stroma, with elevated IL-6 levels observed between 45 and 75 days post-recovery, which were then lower at around day 105. Concurrently, corneal mid-stromal nerve length and branching were initially higher in the 60D to 75D group and returned to control levels by day 135. A similar trend was observed in CD within zones 0 to 2 and 2 to 6 and in the hexagonal cells (HEX) ratio in endothelial cells, whereas ET remained consistent. Notably, these changes did not affect the efficacy, safety, or predictability of post-recovery SMILE surgery. CONCLUSIONS: SARS-CoV-2 induces temporal alterations in corneal stromal morphology and function post-recovery. These findings provided a theoretical basis for corneal health and refractive surgery management in the post-COVID-19 milieu.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Huang Y, Chen T, Chen X, et al. Corneal Stroma Analysis and Related Ocular Manifestations in Recovered COVID-19 Patients. Invest Ophthalmol Vis Sci. 2024. PMID: 38713483. doi:10.1167/iovs.65.5.14

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。